Incyte wins Indian patent injunction just weeks before expiration
US biopharma major Incyte secured an Indian injunction against Melody Healthcare just 11 weeks before its ruxolitinib patent’s expiration. The Delhi High Court ruling highlights the availability of interim protection against...To view the full article, register now.
Already a subscriber? Click here to view full article